VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin

NEXT STORY
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)
PREV STORY
Reata Pharmaceuticals Announces Presentations at Upcoming Medical Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development

ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), ...

author_avatar
NASDAQ Market News

CareSource to lead new statewide Community Transition Program

DAYTON, Ohio, Aug. 16, 2016 (GLOBE NEWSWIRE) -- CareSource, a Dayton-based nonprofit health plan, ...

author_avatar
NASDAQ Market News

Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise

Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise The acquisition of ...

author_avatar
NASDAQ Market News